FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101061910> ?p ?o ?g. }

• W2101061910 endingPage "908" @default.
• W2101061910 startingPage "900" @default.
• W2101061910 abstract "Despite recent advances in targeted therapies and immunotherapies metastatic melanoma remains only rarely curable. The objective of the present study was to identify novel therapeutic targets for metastatic melanoma. A library of 160 well-characterised and potent protein kinase inhibitors was screened in the BRAF mutant cell line Sk-Mel-28, and the NRAS mutant Sk-Mel-2, using proliferation assays. Of the 160 inhibitors tested, 20 achieved >50% growth inhibition in both cell lines. Six of the 20 were cyclin dependent kinase (CDK) inhibitors, including two CDK4 inhibitors. Fascaplysin, a synthetic CDK4 inhibitor, was further tested in 8 melanoma cell lines. The concentration of fascaplysin required to inhibit growth by 50% (IC50 value) ranged from 0.03 to 0.22 µM. Fascaplysin also inhibited clonogenic growth and induced apoptosis. Sensitivity to PD0332991, a therapeutic CDK4/6 inhibitor was also evaluated in the melanoma cell lines. PD0332991 IC50 values ranged from 0.13 to 2.29 µM. Similar to fascaplysin, PD0332991 inhibited clonogenic growth of melanoma cells and induced apoptosis. Higher levels of CDK4 protein correlated with lower sensitivity to PD0332991 in the cell lines. Combined treatment with PD0332991 and the BRAF inhibitor PLX4032, showed additive anti-proliferative effects in the BRAF mutant cell line Malme-3M. In summary, targeting CDK4 inhibits growth and induces apoptosis in melanoma cells in vitro, suggesting that CDK4 may be a rational therapeutic target for metastatic melanoma." @default.
• W2101061910 created "2016-06-24" @default.
• W2101061910 creator A5011649305 @default.
• W2101061910 creator A5021160836 @default.
• W2101061910 creator A5022240564 @default.
• W2101061910 creator A5029977513 @default.
• W2101061910 creator A5043292277 @default.
• W2101061910 creator A5076159971 @default.
• W2101061910 date "2015-07-21" @default.
• W2101061910 modified "2023-10-03" @default.
• W2101061910 title "Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma" @default.
• W2101061910 cites W128422138 @default.
• W2101061910 cites W1516437155 @default.
• W2101061910 cites W1930119421 @default.
• W2101061910 cites W1970920991 @default.
• W2101061910 cites W1979600771 @default.
• W2101061910 cites W1985850253 @default.
• W2101061910 cites W1987860184 @default.
• W2101061910 cites W1989121777 @default.
• W2101061910 cites W1992270075 @default.
• W2101061910 cites W2009489886 @default.
• W2101061910 cites W2022107680 @default.
• W2101061910 cites W2027364423 @default.
• W2101061910 cites W2030070078 @default.
• W2101061910 cites W2036804890 @default.
• W2101061910 cites W2039782788 @default.
• W2101061910 cites W2039992584 @default.
• W2101061910 cites W2046024621 @default.
• W2101061910 cites W2046978924 @default.
• W2101061910 cites W2048949978 @default.
• W2101061910 cites W2061189534 @default.
• W2101061910 cites W2074918415 @default.
• W2101061910 cites W2086571195 @default.
• W2101061910 cites W2090377897 @default.
• W2101061910 cites W2096387850 @default.
• W2101061910 cites W2101085700 @default.
• W2101061910 cites W2134490812 @default.
• W2101061910 cites W2148345265 @default.
• W2101061910 cites W2153451248 @default.
• W2101061910 cites W2154626333 @default.
• W2101061910 cites W2163027927 @default.
• W2101061910 cites W2381391433 @default.
• W2101061910 cites W2599161212 @default.
• W2101061910 cites W3102875255 @default.
• W2101061910 cites W42427648 @default.
• W2101061910 doi "https://doi.org/10.3892/ijo.2015.3097" @default.
• W2101061910 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4532220" @default.
• W2101061910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26201960" @default.
• W2101061910 hasPublicationYear "2015" @default.
• W2101061910 type Work @default.
• W2101061910 sameAs 2101061910 @default.
• W2101061910 citedByCount "17" @default.
• W2101061910 countsByYear W21010619102016 @default.
• W2101061910 countsByYear W21010619102017 @default.
• W2101061910 countsByYear W21010619102018 @default.
• W2101061910 countsByYear W21010619102019 @default.
• W2101061910 countsByYear W21010619102020 @default.
• W2101061910 countsByYear W21010619102021 @default.
• W2101061910 countsByYear W21010619102022 @default.
• W2101061910 countsByYear W21010619102023 @default.
• W2101061910 crossrefType "journal-article" @default.
• W2101061910 hasAuthorship W2101061910A5011649305 @default.
• W2101061910 hasAuthorship W2101061910A5021160836 @default.
• W2101061910 hasAuthorship W2101061910A5022240564 @default.
• W2101061910 hasAuthorship W2101061910A5029977513 @default.
• W2101061910 hasAuthorship W2101061910A5043292277 @default.
• W2101061910 hasAuthorship W2101061910A5076159971 @default.
• W2101061910 hasBestOaLocation W21010619101 @default.
• W2101061910 hasConcept C117262875 @default.
• W2101061910 hasConcept C121608353 @default.
• W2101061910 hasConcept C124320809 @default.
• W2101061910 hasConcept C184235292 @default.
• W2101061910 hasConcept C185592680 @default.
• W2101061910 hasConcept C190283241 @default.
• W2101061910 hasConcept C199649820 @default.
• W2101061910 hasConcept C2775930923 @default.
• W2101061910 hasConcept C2777658100 @default.
• W2101061910 hasConcept C2779707156 @default.
• W2101061910 hasConcept C2779744173 @default.
• W2101061910 hasConcept C29537977 @default.
• W2101061910 hasConcept C502942594 @default.
• W2101061910 hasConcept C530470458 @default.
• W2101061910 hasConcept C54355233 @default.
• W2101061910 hasConcept C55493867 @default.
• W2101061910 hasConcept C62112901 @default.
• W2101061910 hasConcept C81885089 @default.
• W2101061910 hasConcept C86803240 @default.
• W2101061910 hasConcept C98274493 @default.
• W2101061910 hasConceptScore W2101061910C117262875 @default.
• W2101061910 hasConceptScore W2101061910C121608353 @default.
• W2101061910 hasConceptScore W2101061910C124320809 @default.
• W2101061910 hasConceptScore W2101061910C184235292 @default.
• W2101061910 hasConceptScore W2101061910C185592680 @default.
• W2101061910 hasConceptScore W2101061910C190283241 @default.
• W2101061910 hasConceptScore W2101061910C199649820 @default.
• W2101061910 hasConceptScore W2101061910C2775930923 @default.
• W2101061910 hasConceptScore W2101061910C2777658100 @default.
• W2101061910 hasConceptScore W2101061910C2779707156 @default.

• next